InMode Ltd (FRA:154)
€ 15.59 0.49 (3.25%) Market Cap: 1.20 Bil Enterprise Value: 546.44 Mil PE Ratio: 10.03 PB Ratio: 1.77 GF Score: 64/100

Inmode Ltd at Barclays Global Healthcare Conference Transcript

Mar 15, 2023 / 01:30PM GMT
Release Date Price: €29.4 (-2.00%)
Matthew Stephan Miksic
Barclays Bank PLC, Research Division - Research Analyst

Good morning, everybody. We'll begin our next session. My name is Matt Miksic. I cover medical devices here in the U.S. at Barclays. I'm very pleased to have with us today, InMode. We've got Yair Malca, Chief Financial Officer; and we've also got Spero. I'm not going to try to pronounce your last name.

Spero Theodorou
InMode Ltd. - Chief Medical Officer

Okay. Theodorou, like Theodore Roosevelt.

Matthew Stephan Miksic
Barclays Bank PLC, Research Division - Research Analyst

Okay. Theodorou, Chief Medical Officer.

Questions & Answers

Matthew Stephan Miksic
Barclays Bank PLC, Research Division - Research Analyst

So I wanted to maybe start with just one of the things about InMode that I think catches a lot of medical device folks a little bit offguard, and you probably answer this question all the time here, is the growth model. I think the first conversation we had and I'm relatively

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot